Evidence map›Paper›PMID 30991684›Full record

ArticleMolecules (Basel, Switzerland)2019

In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity.

José A H M Bittencourt, Moysés F A Neto, Pedro S Lacerda, Renata C V S Bittencourt, Rai C Silva, Cleison C Lobato, Luciane B Silva, Franco H A Leite, Juliana P Zuliani, Joaquín M C Rosa and 2 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Heliyon · 2023
    Article
  9. Article
  10. Article
  11. Identification of Potential Insect Growth Inhibitor againstInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Computational Approaches for Drug Discovery.Molecules (Basel, Switzerland) · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

José A H M BittencourtGraduate Program of Pharmaceutical Innovation, Federal University of Amapá, Macapá-AP 68902-280, Brazil. joseadolfo@unifap.br.
Moysés F A NetoLaboratory of Molecular Modeling, State University of Feira de Santana, Feira de Santana-BA 44036-900, Brazil. moysesfagundes@gmail.com.
Pedro S LacerdaLaboratory of Bioinformatics and Molecular Modeling, School of Pharmacy, Federal University of Bahia, Barão de Jeremoabo Street, Salvador 40170-115, BA, Brazil. pslacerda@gmail.com.ORCID 0000-0002-0356-9521
Renata C V S BittencourtLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil. recrisvale@hotmail.com.
Rai C SilvaComputational Laboratory of Pharmaceutical Chemistry, University of Sao Paulo, Av. Prof. do Café, s/n - Monte Alegre, Ribeirão Preto, São Paulo 14040-903, Brazil. raics@usp.br.
Cleison C LobatoLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil. cleison@unifap.br.
Luciane B SilvaLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil. luciaanebarros@hotmail.com.
Franco H A LeiteLaboratory of Molecular Modeling, State University of Feira de Santana, Feira de Santana-BA 44036-900, Brazil. fhpharm@gmail.com.ORCID 0000-0003-3166-6051
Juliana P ZulianiLaboratory Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR-364, Porto Velho-RO 78912-000, Brazil. zuliani@fiocruz.br.
Joaquín M C RosaDepartment of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Institute of Biosanitary Research ibs.GRANADA. University of Granada, 18071 Granada, Spain. jmcampos@ugr.es.ORCID 0000-0002-9035-8123
Rosivaldo S BorgesGraduate Program of Pharmaceutical Innovation, Federal University of Amapá, Macapá-AP 68902-280, Brazil. lqfmed@gmail.com.
Cleydson B R SantosGraduate Program of Pharmaceutical Innovation, Federal University of Amapá, Macapá-AP 68902-280, Brazil. breno@unifap.br.ORCID 0000-0002-0271-335X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a complex reaction involving cellular and molecular components and an unspecific response to a specific aggression. The use of scientific and technological innovations as a research tool combining multidisciplinary knowledge in informatics, biotechnology, chemistry and biology are essential for optimizing time and reducing costs in the drug design. Thus, the integration of these in silico techniques makes it possible to search for new anti-inflammatory drugs with better pharmacokinetic and toxicological profiles compared to commercially used drugs. This in silico study evaluated the anti-inflammatory potential of two benzoylpropionic acid derivatives (MBPA and DHBPA) using molecular docking and their thermodynamic profiles by molecular dynamics, in addition to predicting oral bioavailability, bioactivity and toxicity. In accordance to our predictions the derivatives proposed here had the potential capacity for COX-2 inhibition in the human and mice enzyme, due to containing similar interactions with the control compound (ibuprofen). Ibuprofen showed toxic predictions of hepatotoxicity (in human, mouse and rat; toxicophoric group 2-arylacetic or 3-arylpropionic acid) and irritation of the gastrointestinal tract (in human, mouse and rat; toxicophoric group alpha-substituted propionic acid or ester) confirming the literature data, as well as the efficiency of the DEREK 10.0.2 program. Moreover, the proposed compounds are predicted to have a good oral bioavailability profile and low toxicity (LD

Indexed as

Computer SimulationMolecular Docking SimulationAnimalsAnti-Inflammatory Agents, Non-SteroidalBenzoatesCyclooxygenase 2Cyclooxygenase 2 InhibitorsHumansIbuprofenMicePropionatesRatsAnti-Inflammatory Agents, Non-SteroidalBenzoatesbenzoylpropionic acidCyclooxygenase 2Cyclooxygenase 2 InhibitorsIbuprofenPropionatesPTGS2 protein, humanPtgs2 protein, mousebioavailabilityinflammationmolecular dockingmolecular dynamicstoxicity

Identifiers

PMID30991684
PMCPMC6515000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.